Tax Provision - Corcept Therapeutics Inc (NASDAQ:CORT) - Alpha Spread

Corcept Therapeutics Inc
NASDAQ:CORT

Watchlist Manager
Corcept Therapeutics Inc Logo
Corcept Therapeutics Inc
NASDAQ:CORT
Watchlist
Price: 43.93 USD 1.5% Market Closed
Market Cap: 4.8B USD
Have any thoughts about
Corcept Therapeutics Inc?
Write Note

Corcept Therapeutics Inc
Tax Provision

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Corcept Therapeutics Inc
Tax Provision Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors

Company Tax Provision CAGR 3Y CAGR 5Y CAGR 10Y
Corcept Therapeutics Inc
NASDAQ:CORT
Tax Provision
-$23.8m
CAGR 3-Years
-32%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Tax Provision
-$3.1B
CAGR 3-Years
-10%
CAGR 5-Years
-3%
CAGR 10-Years
-5%
Bristol-Myers Squibb Co
NYSE:BMY
Tax Provision
-$109m
CAGR 3-Years
51%
CAGR 5-Years
38%
CAGR 10-Years
13%
Pfizer Inc
NYSE:PFE
Tax Provision
$1.6B
CAGR 3-Years
N/A
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Tax Provision
-$1.5B
CAGR 3-Years
-8%
CAGR 5-Years
6%
CAGR 10-Years
-4%
Eli Lilly and Co
NYSE:LLY
Tax Provision
-$1.6B
CAGR 3-Years
-22%
CAGR 5-Years
-54%
CAGR 10-Years
-7%

See Also

What is Corcept Therapeutics Inc's Tax Provision?
Tax Provision
-23.8m USD

Based on the financial report for Jun 30, 2024, Corcept Therapeutics Inc's Tax Provision amounts to -23.8m USD.

What is Corcept Therapeutics Inc's Tax Provision growth rate?
Tax Provision CAGR 5Y
-7%

Over the last year, the Tax Provision growth was -69%. The average annual Tax Provision growth rates for Corcept Therapeutics Inc have been -32% over the past three years , -7% over the past five years .

Back to Top